相关实验视频
Updated: May 14, 2026

09:33
An Anaerobic Biosensor Assay for the Detection of Mercury and Cadmium
Published on: December 17, 2018
细菌甲基化的遗传基础
Jerry M Parks1, Alexander Johs, Mircea Podar
1Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.
概括
科学家们确定了关键基因hgcA和hgcB,它们负责厌氧细菌的甲基生产. 这一发现揭示了甲基化的遗传基础,这是自然环境中至关重要的过程.
科学领域:
- 环境微生物学 环境微生物学
- 生物地质化学生物地质化学
- 毒理学 毒理学 毒理学
背景情况:
- 甲基是一种强大的神经毒素,由无氧细菌从无机中形成.
- 参与这种甲基化过程的特定基因和蛋白质在很大程度上是未知的.
- 了解这一途径对于环境和健康风险评估至关重要.
研究的目的:
- 为了确定负责细菌中甲基化的基因和蛋白质.
- 为了阐明在自然环境中生产甲基的遗传基础.
- 为了研究不同微生物物种中甲基化途径的保存.
主要方法:
- 在Desulfovibrio desulfuricans ND132和Geobacter sulfurreducens PCA.中进行基因删除实验的基因分析.
- 对测序基因组的生物信息分析,以确定其他细菌和古生物中的同源基因.
- 鉴定出基因产物HgcA和HgcB的生物化学表征.
主要成果:
- 两种基因群,hgcA和hgcB,被确定为在两种研究的细菌物种中对甲基化至关重要.
- 删除hgcA或hgcB取消了甲基化,证实了它们的关键作用.
- 鉴定出HgcA是一种假定的腐化蛋白 (甲基载体),而HgcB是一种2[4Fe-4S]铁素 (电子供体).
- 在已知的甲基化细菌和古生物中发现了hgcA和hgcB的同类物,但在非甲基化物中没有发现,这表明一种保存的途径.
结论:
- hgcA和hgcB基因构成了细菌和古生物中的甲基化核心遗传元件.
- 已识别的蛋白质HgcA和HgcB提供了对甲基化生物化学机制的见解.
- 这一发现表明,甲基化在多种微生物系中具有共同的进化起源,并对理解全球循环产生影响.
相关概念视频
Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Chemotaxis in E. coli
Chemotaxis in Escherichia coli is a sensory-driven motility mechanism that enables bacteria to navigate chemical gradients, moving toward beneficial environments while avoiding harmful conditions. This process relies on a signal transduction system integrating external chemical cues with flagellar motor control.Chemoreceptors and Signal DetectionE. coli detects chemical gradients through methyl-accepting chemotaxis proteins (MCPs), which are membrane-bound chemoreceptors that sense attractants...
Coordination of Gene Expression Processes in Bacteria
The DNA replication, transcription, and translation processes are intricately coupled in bacteria, allowing efficient gene expression and rapid protein synthesis. While this physical and functional coordination is advantageous, it introduces challenges that bacteria overcome through specific regulatory mechanisms.Coupling of Replication, Transcription, and TranslationThe coupling of replication, transcription, and translation is a hallmark of bacterial gene expression. As the replisome unwinds...
Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
